{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:45:05Z","timestamp":1789386305703,"version":"build-2803163510"},"reference-count":89,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jcyt.2017.05.013","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T10:31:50Z","timestamp":1500892310000},"page":"1325-1338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["CCR5-edited gene therapies for HIV cure: Closing the door to viral entry"],"prefix":"10.1016","volume":"19","author":[{"given":"Kevin G.","family":"Haworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Kiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4599","key":"10.1016\/j.jcyt.2017.05.013_bib0010","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.6601823","article-title":"Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)","volume":"220","author":"Gallo","year":"1983","journal-title":"Science"},{"issue":"4599","key":"10.1016\/j.jcyt.2017.05.013_bib0015","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.6189183","article-title":"Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)","volume":"220","author":"Barre-Sinoussi","year":"1983","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jcyt.2017.05.013_bib0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00002030-200301240-00009","article-title":"HIV RNA in plasma rebounds within days during structured treatment interruptions","volume":"17","author":"Fischer","year":"2003","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.jcyt.2017.05.013_bib0025","doi-asserted-by":"crossref","first-page":"F59","DOI":"10.1097\/00002030-199905280-00001","article-title":"Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy","volume":"13","author":"Harrigan","year":"1999","journal-title":"AIDS"},{"issue":"13","key":"10.1016\/j.jcyt.2017.05.013_bib0030","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1097\/QAD.0b013e3281c61394","article-title":"Stopping antiretroviral therapy","volume":"21","author":"Taylor","year":"2007","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.jcyt.2017.05.013_bib0035","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"Hutter","year":"2009","journal-title":"NEJM"},{"issue":"10","key":"10.1016\/j.jcyt.2017.05.013_bib0040","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","article-title":"Evidence for the cure of HIV infection by CCR5 DELTA32\/DELTA32 stem cell transplantation","volume":"117","author":"Allers","year":"2011","journal-title":"Blood"},{"issue":"6605","key":"10.1016\/j.jcyt.2017.05.013_bib0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/384179a0","article-title":"CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5","volume":"384","author":"Wu","year":"1996","journal-title":"Nature"},{"issue":"6593","key":"10.1016\/j.jcyt.2017.05.013_bib0050","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/382722a0","article-title":"Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene","volume":"382","author":"Samson","year":"1996","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jcyt.2017.05.013_bib0055","doi-asserted-by":"crossref","first-page":"e1003347","DOI":"10.1371\/journal.ppat.1003347","article-title":"Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient","volume":"9","author":"Yukl","year":"2013","journal-title":"PLoS Pathog"},{"issue":"6686","key":"10.1016\/j.jcyt.2017.05.013_bib0060","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/31405","article-title":"Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody","volume":"393","author":"Kwong","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2017.05.013_bib0065","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.17.1.657","article-title":"Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease","volume":"17","author":"Berger","year":"1999","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"10.1016\/j.jcyt.2017.05.013_bib0070","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1084\/jem.185.4.621","article-title":"Change in coreceptor use correlates with disease progression in HIV-1\u2013infected individuals","volume":"185","author":"Connor","year":"1997","journal-title":"J Exp Med"},{"issue":"21","key":"10.1016\/j.jcyt.2017.05.013_bib0075","doi-asserted-by":"crossref","first-page":"10674","DOI":"10.1128\/JVI.76.21.10674-10684.2002","article-title":"Selection for human immunodeficiency virus type 1 recombinants in a patient with rapid progression to AIDS","volume":"76","author":"Liu","year":"2002","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.jcyt.2017.05.013_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038755","article-title":"Stochastic model of in-vivo X4 emergence during HIV infection: implications for the CCR5 inhibitor maraviroc","volume":"7","author":"Savkovic","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcyt.2017.05.013_bib0085","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.virol.2016.03.010","article-title":"HIV-1 adaptation to low levels of CCR5 results in V3 and V2 loop changes that increase envelope pathogenicity, CCR5 affinity and decrease susceptibility to Maraviroc","volume":"493","author":"Garg","year":"2016","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.jcyt.2017.05.013_bib0090","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/095632020501600601","article-title":"CCR5 antagonists: host-targeted antivirals for the treatment of HIV infection","volume":"16","author":"Westby","year":"2005","journal-title":"Antivir Chem Chemother"},{"issue":"3","key":"10.1016\/j.jcyt.2017.05.013_bib0095","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0092-8674(00)80110-5","article-title":"Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection","volume":"86","author":"Liu","year":"1996","journal-title":"Cell"},{"issue":"9270","key":"10.1016\/j.jcyt.2017.05.013_bib0100","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(00)04898-4","article-title":"CC chemokine receptor 5 and renal-transplant survival","volume":"357","author":"Fischereder","year":"2001","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jcyt.2017.05.013_bib0105","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.4049\/jimmunol.180.7.4714","article-title":"Combined CXCR3\/CCR5 blockade attenuates acute and chronic rejection","volume":"180","author":"Schnickel","year":"2008","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.jcyt.2017.05.013_bib0110","first-page":"1628","article-title":"CCR5 deletion mutation and its association with the risk of developing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"91","author":"Bogunia-Kubik","year":"2006","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.jcyt.2017.05.013_bib0115","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1371\/journal.pbio.0030339","article-title":"The geographic spread of the CCR5 Delta32 HIV-resistance allele","volume":"3","author":"Novembre","year":"2005","journal-title":"PLoS Biol"},{"issue":"12","key":"10.1016\/j.jcyt.2017.05.013_bib0120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00000446-200312000-00011","article-title":"Bubonic plague and HIV. The delta 32 connection","volume":"103","author":"Goldrick","year":"2003","journal-title":"Am J Nurs"},{"issue":"25","key":"10.1016\/j.jcyt.2017.05.013_bib0125","doi-asserted-by":"crossref","first-page":"15276","DOI":"10.1073\/pnas.2435085100","article-title":"Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele","volume":"100","author":"Galvani","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"10.1016\/j.jcyt.2017.05.013_bib0130","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0198-8859(01)00292-0","article-title":"Distribution of the CCR5 gene 32-basepair deletion in West Europe. A hypothesis about the possible dispersion of the mutation by the Vikings in historical times","volume":"62","author":"Lucotte","year":"2001","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.jcyt.2017.05.013_bib0135","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ng0597-100","article-title":"Global distribution of the CCR5 gene 32-basepair deletion","volume":"16","author":"Martinson","year":"1997","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.jcyt.2017.05.013_bib0140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2893.2004.00510.x","article-title":"Analysis of CCR5-Delta 32 and CCR2-V64I polymorphisms in a cohort of Spanish HCV patients using real-time polymerase chain reaction and fluorescence resonance energy transfer technologies","volume":"11","author":"Ruiz-Ferrer","year":"2004","journal-title":"J Viral Hepat"},{"issue":"2","key":"10.1016\/j.jcyt.2017.05.013_bib0145","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1086\/524691","article-title":"Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic","volume":"197","author":"Lim","year":"2008","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.jcyt.2017.05.013_bib0150","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1086\/524709","article-title":"A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis","volume":"197","author":"Kindberg","year":"2008","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jcyt.2017.05.013_bib0155","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbmt.2009.05.017","article-title":"CCR5 expression on cells from HLA-matched unrelated marrow donors and graft-versus-host disease (Letter to the Editor)","volume":"16","author":"Ma","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jcyt.2017.05.013_bib0160","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1468-1293.2010.00911.x","article-title":"Identification and frequency of CCR5Delta32\/Delta32 HIV-resistant cord blood units from Houston area hospitals","volume":"12","author":"Gonzalez","year":"2011","journal-title":"HIV Med"},{"issue":"25","key":"10.1016\/j.jcyt.2017.05.013_bib0165","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1056\/NEJMc1412279","article-title":"More on shift of HIV tropism in stem-cell transplantation with CCR5 delta32\/delta32 mutation","volume":"371","author":"Hutter","year":"2014","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.jcyt.2017.05.013_bib0170","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1097\/QAD.0000000000001240","article-title":"Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignancies","volume":"30","author":"Mulanovich","year":"2016","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.jcyt.2017.05.013_bib0175","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2249.2010.04312.x","article-title":"Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years (Review)","volume":"163","author":"Hutter","year":"2011","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.jcyt.2017.05.013_bib0180","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1056\/NEJMc1405805","article-title":"Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation","volume":"371","author":"Kordelas","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jcyt.2017.05.013_bib0185","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/cid\/ciu284","article-title":"Dependence on the CCR5 coreceptor for viral replication explains the lack of rebound of CXCR4-predicted HIV variants in the Berlin patient","volume":"59","author":"Symons","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jcyt.2017.05.013_bib0190","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/infdis\/jit086","article-title":"Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation","volume":"207","author":"Henrich","year":"2013","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.jcyt.2017.05.013_bib0195","first-page":"669","article-title":"Allogeneic bone marrow transplantation combined with multiple anti-HIV-1 treatment in a case of AIDS","volume":"12","author":"Contu","year":"1993","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jcyt.2017.05.013_bib0200","doi-asserted-by":"crossref","first-page":"e1004406","DOI":"10.1371\/journal.ppat.1004406","article-title":"Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant","volume":"10","author":"Mavigner","year":"2014","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.jcyt.2017.05.013_bib0205","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7326\/M14-1027","article-title":"Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases","volume":"161","author":"Henrich","year":"2014","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.jcyt.2017.05.013_bib0210","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/QAI.0b013e31828e6163","article-title":"Plasma viremia and cellular HIV-1 DNA persist despite autologous hematopoietic stem cell transplantation for HIV-related lymphoma","volume":"63","author":"Cillo","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.jcyt.2017.05.013_bib0215","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2141.2009.07828.x","article-title":"Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood","volume":"147","author":"Smith","year":"2009","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.jcyt.2017.05.013_bib0220","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1016\/S2352-3018(15)00083-1","article-title":"CCR5 Delta32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report","volume":"2","author":"Duarte","year":"2015","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1016\/j.jcyt.2017.05.013_bib0225","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bbmt.2012.08.019","article-title":"Single cord blood combined with HLA-mismatched third party donor cells: comparable results to matched unrelated donor transplantation in high-risk patients with hematologic disorders","volume":"19","author":"Kwon","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jcyt.2017.05.013_bib0230","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bbmt.2012.10.017","article-title":"Hematopoietic cell transplantation with cord blood for cure of HIV infections","volume":"19","author":"Petz","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jcyt.2017.05.013_bib0235","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.tibtech.2014.12.006","article-title":"Genome editing-based HIV therapies","volume":"33","author":"Gu","year":"2015","journal-title":"Trends Biotechnol"},{"issue":"3","key":"10.1016\/j.jcyt.2017.05.013_bib0240","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/mt.2016.10","article-title":"Genome-editing technologies for gene and cell therapy","volume":"24","author":"Maeder","year":"2016","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.jcyt.2017.05.013_bib0245","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/mthe.2000.0038","article-title":"Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo","volume":"1","author":"Bai","year":"2000","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.jcyt.2017.05.013_bib0250","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1073\/pnas.232688199","article-title":"Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5","volume":"100","author":"Qin","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcyt.2017.05.013_bib0255","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.addr.2016.03.005","article-title":"Recent advances in RNAi-based strategies for therapy and prevention of HIV-1\/AIDS","volume":"103","author":"Swamy","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"10.1016\/j.jcyt.2017.05.013_bib0260","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nbt1410","article-title":"Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases","volume":"26","author":"Perez","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1016\/j.jcyt.2017.05.013_bib0265","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1534\/genetics.110.120717","article-title":"Targeting DNA double-strand breaks with TAL effector nucleases","volume":"186","author":"Christian","year":"2010","journal-title":"Genetics"},{"issue":"6096","key":"10.1016\/j.jcyt.2017.05.013_bib0270","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jcyt.2017.05.013_bib0275","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/nar\/gkt1224","article-title":"megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering","volume":"42","author":"Boissel","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.jcyt.2017.05.013_bib0280","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.jcyt.2017.05.013_bib0285","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1128\/mr.57.1.183-289.1993","article-title":"Pathogenesis of human immunodeficiency virus infection","volume":"57","author":"Levy","year":"1993","journal-title":"Microbiol Rev"},{"issue":"2","key":"10.1016\/j.jcyt.2017.05.013_bib0290","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1182\/blood-2013-01-482224","article-title":"Positive selection of mC46-expressing CD4+ T cells and maintenance of virus specific immunity in a primate AIDS model","volume":"122","author":"Younan","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jcyt.2017.05.013_bib0295","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1128\/JVI.03428-13","article-title":"The majority of CD4+ T-cell depletion during acute simian-human immunodeficiency virus SHIV89.6P infection occurs in uninfected cells","volume":"88","author":"Matrajt","year":"2014","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.jcyt.2017.05.013_bib0300","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1073\/pnas.98.2.658","article-title":"Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus\/HIV type 1 chimera (SHIV): implications for HIV-1 infections of humans","volume":"98","author":"Igarashi","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.jcyt.2017.05.013_bib0305","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.ajpath.2011.06.039","article-title":"Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals","volume":"179","author":"Thompson","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcyt.2017.05.013_bib0310","doi-asserted-by":"crossref","first-page":"24157","DOI":"10.1038\/srep24157","article-title":"Monocyte-derived macrophages exhibit distinct and more restricted HIV-1 integration site repertoire than CD4(+) T cells","volume":"6","author":"Kok","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2017.05.013_bib0315","doi-asserted-by":"crossref","DOI":"10.1089\/hum.2016.107","article-title":"Gene editing of human hematopoietic stem and progenitor cells: promise and potential hurdles","author":"Yu","year":"2016","journal-title":"Hum Gene Ther"},{"issue":"8","key":"10.1016\/j.jcyt.2017.05.013_bib0320","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.1663","article-title":"Human hematopoietic stem\/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo","volume":"28","author":"Holt","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"20","key":"10.1016\/j.jcyt.2017.05.013_bib0325","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1182\/blood-2015-09-672337","article-title":"Long-term multilineage engraftment of autologous genome-edited hematopoietic stem cells in nonhuman primates","volume":"127","author":"Peterson","year":"2016","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jcyt.2017.05.013_bib0330","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"NEJM"},{"issue":"3","key":"10.1016\/j.jcyt.2017.05.013_bib0335","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/cmdc.200500062","article-title":"Stable expression of soluble therapeutic peptides in eukaryotic cells by multimerisation: application to the HIV-1 fusion inhibitory peptide C46","volume":"1","author":"Dervillez","year":"2006","journal-title":"ChemMedChem"},{"issue":"2","key":"10.1016\/j.jcyt.2017.05.013_bib0340","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1128\/AAC.01152-12","article-title":"A rationally engineered anti-HIV peptide fusion inhibitor with greatly reduced immunogenicity","volume":"57","author":"Brauer","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcyt.2017.05.013_bib0345","doi-asserted-by":"crossref","first-page":"16007","DOI":"10.1038\/mtm.2016.7","article-title":"Multilineage polyclonal engraftment of Cal-1 gene-modified cells and in vivo selection after SHIV infection in a nonhuman primate model of AIDS","volume":"3","author":"Peterson","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"7","key":"10.1016\/j.jcyt.2017.05.013_bib0350","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1172\/JCI40767","article-title":"Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates","volume":"120","author":"Beard","year":"2010","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.jcyt.2017.05.013_bib0355","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jcyt.2017.05.013_bib0360","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.jcyt.2017.05.013_bib0365","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1089\/hum.2011.126","article-title":"Generation of CD34+ cells from CCR5-disrupted human embryonic and induced pluripotent stem cells","volume":"23","author":"Yao","year":"2012","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jcyt.2017.05.013_bib0370","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1038\/mtna.2015.42","article-title":"CCR5 disruption in induced pluripotent stem cells using CRISPR\/Cas9 provides selective resistance of immune cells to CCR5-tropic HIV-1 virus","volume":"4","author":"Kang","year":"2015","journal-title":"Mol Ther Nucleic Acids"},{"issue":"26","key":"10.1016\/j.jcyt.2017.05.013_bib0375","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.1073\/pnas.1407473111","article-title":"Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Delta32 mutation confers resistance to HIV infection","volume":"111","author":"Ye","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.jcyt.2017.05.013_bib0380","first-page":"5","article-title":"Targeted genome engineering in human induced pluripotent stem cells by penetrating TALENs","volume":"2","author":"Ru","year":"2013","journal-title":"Cell Regen (Lond)"},{"issue":"5","key":"10.1016\/j.jcyt.2017.05.013_bib0385","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1182\/blood-2005-06-2335","article-title":"Survival of the fittest: in vivo selection and stem cell gene therapy (Review)","volume":"107","author":"Neff","year":"2006","journal-title":"Blood"},{"issue":"7042","key":"10.1016\/j.jcyt.2017.05.013_bib0390","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature03556","article-title":"Highly efficient endogenous human gene correction using designed zinc-finger nucleases","volume":"435","author":"Urnov","year":"2005","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.jcyt.2017.05.013_bib0395","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1073\/pnas.0611478104","article-title":"Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases","volume":"104","author":"Moehle","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcyt.2017.05.013_bib0400","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.omtm.2016.12.008","article-title":"Homology-directed recombination for enhanced engineering of chimeric antigen receptor T cells","volume":"4","author":"Hale","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"2","key":"10.1016\/j.jcyt.2017.05.013_bib0405","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4049\/jimmunol.1600343","article-title":"The latent reservoir for HIV-1: how immunologic memory and clonal expansion contribute to HIV-1 persistence","volume":"197","author":"Murray","year":"2016","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.jcyt.2017.05.013_bib0410","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.tim.2016.01.006","article-title":"HIV-1 reservoirs during suppressive therapy","volume":"24","author":"Barton","year":"2016","journal-title":"Trends Microbiol"},{"issue":"307","key":"10.1016\/j.jcyt.2017.05.013_bib0415","doi-asserted-by":"crossref","first-page":"307ra156","DOI":"10.1126\/scitranslmed.aac5530","article-title":"Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template","volume":"7","author":"Sather","year":"2015","journal-title":"Sci Transl Med"},{"issue":"7355","key":"10.1016\/j.jcyt.2017.05.013_bib0420","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature10177","article-title":"In vivo genome editing restores haemostasis in a mouse model of haemophilia","volume":"475","author":"Li","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jcyt.2017.05.013_bib0425","doi-asserted-by":"crossref","first-page":"e91230","DOI":"10.1172\/jci.insight.91230","article-title":"Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation","volume":"2","author":"Peterson","year":"2017","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.jcyt.2017.05.013_bib0430","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.3390\/v7082816","article-title":"CCR5 targeted cell therapy for HIV and prevention of viral escape","volume":"7","author":"Hutter","year":"2015","journal-title":"Viruses"},{"issue":"13","key":"10.1016\/j.jcyt.2017.05.013_bib0435","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1097\/QAD.0000000000000702","article-title":"Lack of viral control and development of combination antiretroviral therapy escape mutations in macaques after bone marrow transplantation","volume":"29","author":"Peterson","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.jcyt.2017.05.013_bib0440","doi-asserted-by":"crossref","first-page":"13173","DOI":"10.1038\/ncomms13173","article-title":"Semi-automated closed system manufacturing of lentivirus gene-modified haematopoietic stem cells for gene therapy","volume":"7","author":"Adair","year":"2016","journal-title":"Nat Commun"},{"issue":"18","key":"10.1016\/j.jcyt.2017.05.013_bib0445","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1182\/blood-2016-04-711580","article-title":"In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors","volume":"128","author":"Richter","year":"2016","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.jcyt.2017.05.013_bib0450","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood-2013-11-538926","article-title":"Intravenous injection of a foamy virus vector to correct canine SCID-X1","volume":"123","author":"Burtner","year":"2014","journal-title":"Blood"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324917306205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324917306205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:33:02Z","timestamp":1761442382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324917306205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":89,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1465324917306205"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2017.05.013","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CCR5-edited gene therapies for HIV cure: Closing the door to viral entry","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2017.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}